Dongwha Pharm.Co.,Ltd (KRX:000020)
South Korea · Delayed Price · Currency is KRW 4,760.00
+80.00 (1.71%)
Aug 3, 2026, 3:30 PM KST
Dongwha Pharm.Co.,Ltd Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 501,334 | 496,394 | 464,875 | 361,109 | 340,426 | 293,018 |
Revenue Growth | 6.29% | 6.78% | 28.73% | 6.08% | 16.18% | 7.70% |
Gross Profit Gross Profit Growth | 223,411 | 218,547 | 214,258 | 190,416 | 180,990 | 149,347 |
Operating Income Operating Income Growth | 8,716 | -243.25 | 13,411 | 18,666 | 29,915 | 22,499 |
Net Income Net Income Growth | 18,671 | 8,686 | 5,563 | 27,438 | 20,383 | 17,870 |
Earnings Per Share EPS Growth | 716.34 | 313.37 | 201.00 | 991.07 | 736.42 | 646.68 |
EPS Growth | 705.13% | 55.91% | -79.72% | 34.58% | 13.88% | -37.37% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 22,005 | 24,374 | 43,497 | 88,830 | 107,695 | 121,510 |
Total Debt Total Debt Growth | 127,026 | 123,204 | 96,990 | 47,100 | 6,664 | 11,474 |
Net Cash (Debt) Net Cash Growth | -105,021 | -98,830 | -53,493 | 41,730 | 101,031 | 110,036 |
Net Cash Growth | - | - | - | -58.70% | -8.18% | 5.15% |
Net Cash Per Share Net Cash Per Share Growth | -4029.25 | -3565.55 | -1932.70 | 1507.27 | 3650.06 | 3981.90 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 13,589 | 15,699 | -4,003 | 29,167 | 29,221 | 36,031 |
Capital Expenditures CapEx Growth | -44,928 | -54,140 | -36,685 | -24,541 | -18,428 | -21,944 |
Free Cash Flow Free Cash Flow Growth | -31,339 | -38,442 | -40,689 | 4,626 | 10,792 | 14,087 |
Free Cash Flow Growth | - | - | - | -57.14% | -23.39% | -21.66% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 44.56% | 44.03% | 46.09% | 52.73% | 53.17% | 50.97% |
Operating Margin | 1.74% | -0.05% | 2.89% | 5.17% | 8.79% | 7.68% |
Pretax Margin | 2.67% | 1.21% | 1.48% | 10.23% | 6.78% | 9.05% |
Profit Margin | 3.72% | 1.75% | 1.20% | 7.60% | 5.99% | 6.10% |
FCF Margin | -6.25% | -7.74% | -8.75% | 1.28% | 3.17% | 4.81% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 180.000 | - | - | 180.000 | 180.000 | 180.000 |
Dividend Per Share Growth | -63.89% | - | - | 0% | 0% | 0% |
Dividend Yield | 3.85% | - | - | 1.82% | 2.06% | 1.33% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.64 | 19.94 | 31.39 | 10.36 | 12.57 | 22.61 |
P/FCF Ratio | - | - | - | 61.45 | 23.75 | 28.69 |
PS Ratio | 0.26 | 0.35 | 0.38 | 0.79 | 0.75 | 1.38 |